Grabowski Benjamin, Schmidt M Alexander, Rüter Christian
a Institute of Infectiology - Centre for Molecular Biology of Inflammation (ZMBE), University of Münster , Münster , Germany.
Virulence. 2017 Oct 3;8(7):1124-1147. doi: 10.1080/21505594.2017.1303588. Epub 2017 Mar 15.
Human-pathogenic Yersinia produce plasmid-encoded Yersinia outer proteins (Yops), which are necessary to down-regulate anti-bacterial responses that constrict bacterial survival in the host. These Yops are effectively translocated directly from the bacterial into the target cell cytosol by the type III secretion system (T3SS). Cell-penetrating peptides (CPPs) in contrast are characterized by their ability to autonomously cross cell membranes and to transport cargo - independent of additional translocation systems. The recent discovery of bacterial cell-penetrating effector proteins (CPEs) - with the prototype being the T3SS effector protein YopM - established a new class of autonomously translocating immunomodulatory proteins. CPEs represent a vast source of potential self-delivering, anti-inflammatory therapeutics. In this review, we give an update on the characteristic features of the plasmid-encoded Yops and, based on recent findings, propose the further development of these proteins for potential therapeutic applications as natural or artificial cell-penetrating forms of Yops might be of value as bacteria-derived biologics.
人类致病性耶尔森氏菌可产生质粒编码的耶尔森氏菌外膜蛋白(Yops),这些蛋白对于下调限制细菌在宿主体内存活的抗菌反应是必需的。这些Yops可通过III型分泌系统(T3SS)有效地直接从细菌转运至靶细胞胞质溶胶中。相比之下,细胞穿透肽(CPPs)的特征在于其能够自主穿过细胞膜并运输货物,而无需额外的转运系统。最近发现的细菌细胞穿透效应蛋白(CPEs)——以T3SS效应蛋白YopM为原型——确立了一类新的自主转运免疫调节蛋白。CPEs是潜在的自我递送抗炎治疗药物的丰富来源。在本综述中,我们更新了质粒编码Yops的特征,并基于最近的研究结果,提出进一步开发这些蛋白用于潜在治疗应用,因为天然或人工细胞穿透形式的Yops作为细菌衍生的生物制品可能具有价值。